rubella

GPTKB entity

Statements (58)
Predicate Object
gptkbp:instance_of gptkb:healthcare_organization
gptkbp:bfsLayer 5
gptkbp:bfsParent gptkb:Rubella_vaccine
gptkbp:caused_by gptkb:rubella_virus
gptkbp:clinical_trial mild illness in children
more severe in adults
gptkbp:common_name gptkb:German_measles
gptkbp:complications gptkb:congenital_rubella_syndrome
gptkbp:contraindication pregnant women
immunocompromised individuals
gptkbp:current_use gptkb:psychologist
deafness
cataracts
cardiac defects
thrombocytopenic purpura
gptkbp:duration lifetime after infection
gptkbp:genetic_diversity single serotype
gptkbp:genus gptkb:Rubivirus
gptkbp:geographical_feature worldwide
gptkbp:historical_event first described in 1752
https://www.w3.org/2000/01/rdf-schema#label rubella
gptkbp:hunting_technique subcutaneous injection
gptkbp:incubation_period 2 to 3 weeks
gptkbp:is_protected_by vaccination
gptkbp:is_recognized_by gptkb:hospital
gptkbp:is_tested_for PCR testing
Ig M antibody detection
gptkbp:is_vulnerable_to gptkb:MMR_vaccine
rash
refrigerated
live attenuated vaccine
mild fever
rare allergic reactions
95% or higher
reduced incidence of disease
arthralgia
administered at 12-15 months
booster at 4-6 years
decreased congenital rubella syndrome cases
introduced in 1969
routine childhood vaccination
gptkbp:nutritional_value gptkb:Togaviridae
gptkbp:public_awareness immunization programs
important for vaccination
gptkbp:risk_factor pregnant women
gptkbp:scientific_classification vaccine-preventable disease
gptkbp:scientific_goals gptkb:2020_target_by_WHO
gptkbp:screenings before pregnancy
gptkbp:social_responsibility vaccination campaigns
serological testing
common in unvaccinated populations
declined due to vaccination
gptkbp:symptoms fever
rash
lymphadenopathy
gptkbp:transmission airborne droplets
from mother to fetus
gptkbp:treatment supportive care